Third generation oral contraceptives and vascular risks

European Journal of Public Health

Volumn 12, Issue 2, 2002, Pages 81-82

  La, Vecchia Carlo ^a   Silvia, Franceschi ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; ETHINYLESTRADIOL; GESTAGEN; GESTODENE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

EDITORIAL; HEART INFARCTION; HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE; THROMBOEMBOLISM;

CEREBROVASCULAR ACCIDENT; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS;

EID: 0036087976     PISSN: 11011262     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurpub/12.2.81     Document Type: Editorial

References (13)

1. Third generation oral contraceptives: Caution is still justified
2. Oral contraceptives and the risk of venous thrombosis
3. Oral contraceptives any myocardial infarction: The search for the smoking gun
4. Adjusting Europe's regulation to public health needs
5. Risk of acute myocardial infarction and low-dose combined oral contraceptives
6. Third generation oral contraceptives and risk of myocardial infarction: An international case-control study
7. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women
8. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study
9. Oral contraceptives and myocardial infarction: Results of the MICA case-control study
10. Oral contraceptives and the risk of myocardial infarction
11. Meta-analysis of observational studies in epidemiology
12. The effects of different formulation of oral contraceptive agents on lipid and carbohydrate metabolism
13. Evaluation of a new generation of oral contraceptives